Choose from the list of impairments to see what John Hancock's underwriters look for and likely underwriting risk classifications or rating.
The most common gynecological malignancy.
Likely Underwriting Decision
Preferred may be available once Standard rates for 5 years for Stage IA well or moderately differentiated uterine cancer
Best Case: Stage IA, Grade 1, well differentiated endometroid or mucinous carcinoma – Standard following completion of successful treatment
Typical Case: Stage IB endrometial carcinoma – PP x 1 year then $10/1000 x 4 years
Worst Case: Stage IV decline
Factors Affecting the Decision
- Date of diagnosis
- Type, stage and grade of uterine cancer (endometroid, papillary, serous, etc.)
- Any recurrence
Fast Track the App
- Pathology reports
- Treatment and hospital report
- Evidence of regular follow-up